from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0977/PE_PGRS16

LFCtreatmentdescriptionclass of inhibitor

1.037

Amikacinug/mL Amikacintranslation

0.125

Cap5-10ug/mL Capreomycintranslation

0.551

Rox10-50 ug/mL Roxithromycintranslation

-0.147

SM2-5 ug/mL Streptomycintranslation

0.962

Tet5-10 ug/mL Tetracyclinetranslation

1.056

Rif0.2-5ug/mL Rifampicintranscription

0.555

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.483

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.197

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.797

CPZ10-50 ug/mL Chlorpromazinerespiration

0.401

Clofazimine10-13 ug/mL Clofaziminerespiration

1.589

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.661

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.707

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.573

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.273

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.861

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.004

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.864

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.816

KCN5-20 ug/mL Potassium cyaniderespiration

0.366

NaN30.2-2 mM Sodium aziderespiration

0.705

Nigericin50 uM Nigericinrespiration

0.173

TRC10-150 ug/mL Triclosanrespiration

0.244

TRZ10-25 ug/mL Thioridazinerespiration

-0.069

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.628

menadione6-10 ug/mL Menadionerespiration

0.523

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.000

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.780

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.395

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.418

NRP_1Non-replicating persistence stage 1dosRassociated

-0.772

Amp0.2mg/mL AmpicillincellWall

-0.253

Cephalexin20-100 ug/mL CephalexincellWall

0.494

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.012

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.469

EMB10-20 ug/mL EthambutolcellWall

0.129

Eta12-40 ug/mL EthionamidecellWall

-0.594

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.496

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.119

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.185

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.726

BZA0.12 mg/mL BenzamidearomaticAmides

-0.286

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.609

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.495

H2O24 mM hydrogen peroxideDNAdamaging

0.202

Levo10 ug/mL LevofloxacinDNAdamaging

-0.644

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.623

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.309

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.296

UVUV-irradiationDNAdamaging

-0.200

ARP41-4 ug/mL Antitubercular compound ARP4?

1.987

Antimycin12.5-50 ug/mL Antimycin A?

0.143

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

2.239

PA_110-50 ug/mL Antitubercular compound PA-1?

0.596

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.218

PA8240.2-2 ug/mL PA-824?

0.385

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.728

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.188

Verapamil50 uM Verapamil?

-0.129

mercaptoethanol2 mM 2-Mercaptoethanol?

0.151

methoxatin10-20 ug/mL Methoxatin?